We are in the midst of a psychedelic renaissance,” writer guest author Pam Conboy. “Psilocybin, the active compound in ‘magic mushrooms,’ has demonstrated both a ...

The March of Dimes awarded a grant to further research into profiling the vaginal microbiome and investigate its connection ...

In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...

Studying drug-induced metabolic changes with high-throughput systems shed light on drug modes of action, providing an ...

Shorla Oncology (?Shorla'), a U.S.-Ireland specialty pharmaceutical company, today announced the launch of a dedicated sales force and market access teams and the commercial availability of IMKELDI, ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the approval and ...

Individuals’ metabolomic marker profiles may predict the onset of inflammatory bowel disease a decade in advance, underlining ...

This article outlines the role of gut bacteria on mental health. This article outlines the positive benefit it is having.

A group of gut bacteria successfully hindered recurrent Clostridium difficile infection in mice, offering alternative ...

A streamlined synthesis of the psychoactive compound ibogaine could open up new opportunities in the treatment of drug ...

StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note released on Sunday morning. The brokerage issued a sell rating on the stock. Ayala ...

Gut-microbiota has been found in recent years to have a significant impact on both physical and mental health. Ted Dinan, the ...